Subscribe to Newsletter

Melanie Kelly

The Power List 2020 – R&D Trailblazers

Melanie Kelly

Professor of Pharmacology, Ophthalmology & Visual Sciences, Anesthesia, Perioperative Medicine and Pain Management, Dalhousie University, Nova Scotia, Canada

Motivation: To develop new drugs that target elements of the endocannabinoid system to treat inflammatory and neurodegenerative disease.

Starting out in cannabis science: A collaboration initiated in 1998 with a colleague and friend, Orlando Hung, and his research team. He approached me to work on the pharmacology of a new inhalation delivery platform for cannabinoids. He believed that there were superior and safer ways to deliver THC via inhalation that did not involve smoking and that could provide effective pain relief for patients. This was my first scientific exposure to THC and cannabinoids and kickstarted a scientific journey for me in endocannabinoid research that now spans more than two decades.

The next 10 years: This is an exciting time in endocannabinoid research due to the high level of public interest and the changed political landscape for cannabis. I strongly believe that the next decade will lead to a greater understanding of the body’s endocannabinoid system and result in breakthrough new therapeutics. Production, analysis and manufacturing technologies that are emerging in the cannabis industry will drive innovation elsewhere.

Part of the Power List

Find out more

Highlighting the Top 20 scientists in two categories: cannabis analysis and cannabis research.

Go to The Power List 2020

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine